OCC 2.50% 39.0¢ orthocell limited

Ann: CelGro Nerve Regeneration Results in Quadriplegic Patients, page-256

  1. 2,194 Posts.
    lightbulb Created with Sketch. 359
    @bedger , Possible partnership with J&J it is mostly speculation?

    What do you think in the event that a partnership is not formed with J&J, in regards to the value of OCC and short/long term
    future of OCC?

    Also, In late April/ early May OCC had a CR for $10.4M to be used to fast track marketing.

    Following that OCC had a few annies , such as dental. We saw SP get up to 57c. Obviously based on the annies.
    Based on those annies the SP didn't slide down all the way back down straight away.

    What would be a fair time frame for OCC to justify the CR to fast track marketing? (As we require OCC to increase revenue and profits to keep
    the SP higher.)
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.